New York Cancer and Blood Specialists Revenue and Competitors
Estimated Revenue & Valuation
- New York Cancer and Blood Specialists's estimated annual revenue is currently $223.4M per year.
- New York Cancer and Blood Specialists's estimated revenue per employee is $337,500
Employee Data
- New York Cancer and Blood Specialists has 662 Employees.
- New York Cancer and Blood Specialists grew their employee count by 21% last year.
New York Cancer and Blood Specialists's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Radiology Officer | Reveal Email/Phone |
3 | Chief Development Officer (CDO) | Reveal Email/Phone |
4 | Chief Operating Officer | Reveal Email/Phone |
5 | Chief Information Officer | Reveal Email/Phone |
6 | Co-Chief Medical Officer | Reveal Email/Phone |
7 | Co-Chief Medical Officer | Reveal Email/Phone |
8 | Chief Supportive and Palliative Care Team | Reveal Email/Phone |
9 | Chief Staff | Reveal Email/Phone |
10 | Chief Laboratory and Pathology Services | Reveal Email/Phone |
New York Cancer and Blood Specialists Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $49.9M | 168 | 2% | N/A | N/A |
#2 | $300.1M | 794 | -9% | N/A | N/A |
#3 | $10.2M | 47 | 4% | N/A | N/A |
#4 | $23.5M | 87 | 32% | N/A | N/A |
#5 | $30.5M | 113 | 8% | N/A | N/A |
#6 | $31.9M | 118 | 9% | N/A | N/A |
#7 | $26.5M | 98 | -2% | N/A | N/A |
#8 | $4.9M | 26 | -13% | N/A | N/A |
#9 | $75.7M | 255 | 4% | N/A | N/A |
#10 | $229.4M | 669 | 3% | $177.7M | N/A |
What Is New York Cancer and Blood Specialists?
Walk into any of our 20 (and counting) New York Cancer & Blood Specialists locations and you will immediately feel why we are a community oncology treatment center, which strives to be close and convenient to your home. As our patient, you and your health come first, always. This is where our difference begins.
keywords:N/A
N/A
Total Funding
662
Number of Employees
$223.4M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator